DHODH-IN-22
DHODH-IN-22 is a potent, selective and orally active dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 value of 0.3 nM. DHODH-IN-22 can be used for researching acute myelogenous leukemia (AML) [1].
Product Specifications
CAS Number
[2450341-75-8]
UNSPSC
12352005
Target
Dihydroorotate Dehydrogenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dhodh-in-22.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(F)=C(N2N=C(CO)N(CC)C2=O)N=C1O[C@@H](C)C(F)(F)F)NC3=C(Cl)C(OC)=NC=C3C
Molecular Formula
C21H21ClF4N6O5
Molecular Weight
548.88
References & Citations
[1]Cisar JS, et al. N-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. J Med Chem. 2022 Aug 4.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RALBP1 (RLIP1, RLIP76, RalA-binding Protein 1, 76kD Ral-interacting Protein, Dinitrophenyl S-glutathione ATPase, DNP-SG ATPase, Ral-interacting Protein 1) (APC)
(21E/Z,36Z) -2-Docosyl-3-hydroxy-21,36-pentapentacontadienoic Acid